Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/08/2019.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-165-05
- Dosage Form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)
- Initial Posting
- 02/08/2019
- Revised Date